HemaCell
PrivateLast Round
Series B
Jun 2, 2026
Total Funding Raised
$57.3M
Company Overview
HemaCell is a biotechnology company that develops stem cell-based therapeutics for the regeneration of blood cells to treat various diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemaCell Comparables
Compare HemaCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HemostOD SA | 83% | |
| Megakaryon Corporation | 80% | |
| Stellular Bio | 77% | |
HemaCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 2, 2026 | ||||
| VC Round | Jan 8, 2025 | ||||
| Series A | Dec 19, 2023 | ||||
| VC Round | May 27, 2022 | ||||
| Pre Seed | Feb 25, 2022 | ||||
Seed | Oct 9, 2021 |
HemaCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | Series A |
| 招银国际金融有限公司 | Pre Seed |
| Wedo Venture Partners | Series B, Pre Seed, VC Round, Seed |
| Northern Light Venture Capital | Pre Seed, VC Round |
| Country Garden Ventures Capital | Pre Seed, VC Round |
| Luxin Venture Capital Group | VC Round |
| Founder Hesheng Investment Co., Ltd. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
Completed a VC Round fundraise.
- Dec 19, 2023
Led by Zhongbo Juli with participation from CDH Investments.
HemaCell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HemaCell's valuation, stock price, and market status.